1. Home
  2. BRKR vs RDY Comparison

BRKR vs RDY Comparison

Compare BRKR & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bruker Corporation

BRKR

Bruker Corporation

SELL

Current Price

$61.38

Market Cap

8.6B

Sector

Industrials

ML Signal

SELL

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

SELL

Current Price

$14.80

Market Cap

9.9B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BRKR
RDY
Founded
1960
1984
Country
United States
India
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
9.9B
IPO Year
2000
2001

Fundamental Metrics

Financial Performance
Metric
BRKR
RDY
Price
$61.38
$14.80
Analyst Decision
Buy
Buy
Analyst Count
13
5
Target Price
★ $68.00
$14.79
AVG Volume (30 Days)
2.5M
★ 2.5M
Earning Date
11-04-2026
10-23-2026
Dividend Yield
0.33%
★ 0.44%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,895,600,000.00
N/A
Revenue This Year
$3.00
$4.58
Revenue Next Year
$4.22
$11.95
P/E Ratio
★ N/A
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$32.37
$11.36
52 Week High
$68.98
$15.67

Technical Indicators

Market Signals
Indicator
BRKR
RDY
Relative Strength Index (RSI) 52.10 69.38
Support Level $53.32 $12.91
Resistance Level $63.77 $15.08
Average True Range (ATR) 3.86 0.24
MACD 0.09 -0.02
Stochastic Oscillator 45.55 73.30

Price Performance

Historical Comparison
BRKR
RDY

About BRKR Bruker Corporation

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: